Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Rectal Neoplasms 2Pancreatic Neoplasms 2Colorectal Neoplasms 2Surgical Wound Infection 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Mouth Neoplasms 1Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1Head and Neck Neoplasms 1Adenocarcinoma 1

Interventions

sipuleucel-T 1enzalutamide 1Vancomycin 1Metronidazole 1Ciprofloxacin 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Metastatic Castration-Resistant Prostate Cancer (mCRPC) × Metronidazole × Clear all
NCT06126731 2025-11-24

Combination Study of Antibiotics With Enzalutamide (PROMIZE)

Institute of Cancer Research, United Kingdom

Phase 1/2 Recruiting
39 enrolled
Genitourinary

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡